Medical White Papers

RSS

Medical White Papers are in-depth articles aimed to educate and inform site visitors interested in medical research. Some of these papers are derived from sources where we have existing commercial relationships. Such articles are clearly labelled as sponsored content and are only accepted when the content is deemed to add value to the core editorial ethos of News Medical.

Biomarkers hold the key to more personalized medicine

Biomarkers hold the key to more personalized medicine

As the need for personalized medicine is made more apparent by the inefficiency of some treatments against particular illnesses, biomarkers are offering benefits in the drug development process that cannot be overlooked.

From Cerba Research 5 Apr 2022

Cerba strives to boost research in immuno-oncology

Cerba strives to boost research in immuno-oncology

Immuno-oncology is a promising cancer treatment approach that relies on immune regulation. It is particularly interesting as it could offer solutions for cancers that resist other forms of treatment.

From Cerba Research 5 Apr 2022

Cerba’s ‘patient first’ ideology is at the heart of its identity

Cerba’s ‘patient first’ ideology is at the heart of its identity

Cerba's mission is to help improve clinical trials, but the ultimate goal is to make patients' lives easier. We are striving for safer, more comfortable processes to relieve patients of unnecessary stress, and that has been at the heart of Cerba's approach from the very first day.

From Cerba Research 5 Apr 2022

Cerba Research partners with the Gustave Roussy Institute to improve patient experience

Cerba Research partners with the Gustave Roussy Institute to improve patient experience

Immuno-oncology (IO) trials can be a great chance for participating patients to fight cancer, but the complex logistics behind them can prove difficult for the patient.

From Cerba Research 5 Apr 2022

The power of flow cytometry in cancer research

The power of flow cytometry in cancer research

Flow cytometry is used in immunotherapy research to measure and monitor immune responses.

From Cerba Research 5 Apr 2022

Biomarkers hold the key to better clinical outcomes

Biomarkers hold the key to better clinical outcomes

Biomarkers hold the key to more efficient, more successful drug development and can remedy this issue.

From Cerba Research 5 Apr 2022

Custom flow cytometry assays are critical to personalized medicine

Custom flow cytometry assays are critical to personalized medicine

Cerba Research have 25 years of extensive expertise in providing Phase I to Phase III flow cytometry testing for clinical trials, and are proud of a strong track record of developing custom-made flow cytometry panels.

From Cerba Research 5 Apr 2022

Cerba Research offers state-of-the-art in-vitro diagnostics

Cerba Research offers state-of-the-art in-vitro diagnostics

Cerba offers in-vitro diagnostics to boost and optimize client trials and your testing potential.

From Cerba Research 5 Apr 2022

Optimize clinical trials with Cerba Research high-end operational support

Optimize clinical trials with Cerba Research high-end operational support

From logistics to data management, high-end operational support is key for Cerba and its partners.

From Cerba Research 5 Apr 2022

Alleviating the complexity of rare disease research

Alleviating the complexity of rare disease research

Rare diseases can be especially difficult to research - be it because of staff shortages or access to remote sites.

From Cerba Research 5 Apr 2022

Rapid innovations in histopathology will change the face of clinical trials

Rapid innovations in histopathology will change the face of clinical trials

Histopathology is undergoing rapid innovations due to the rise of precision medicine.

From Cerba Research 5 Apr 2022

Cerba Research extends facilities provided by U.S Immuno-Oncology Center of Excellence

Cerba Research extends facilities provided by U.S Immuno-Oncology Center of Excellence

This article outlines how Cerba Research U.S benefited from moving their Center of Excellence to a larger facility.

From Cerba Research 5 Apr 2022

Analyzing pesto and GCxGC

Analyzing pesto and GCxGC

This article describes how LECO's Pegasus® BT 4D is able to analyze GCxGC TOFMS in pesto to isolate the specific elements that make some recipes better than others.

From LECO Corporation 1 Apr 2022

Meat moisture analysis made easy

Meat moisture analysis made easy

Moisture is a critical metric to monitor that highly influences the quality and safety of meat. LECO's TGM800 is a powerful tool for meat moisture analysis, as described in this article.

From LECO Corporation 1 Apr 2022

Investigating fentanyl and counterfeit drugs

Investigating fentanyl and counterfeit drugs

Fentanyl is extremely potent, and as such is sometimes illicitly used to cut other narcotics, such as heroin or oxycodone. However, it can be lethal even in small doses. In this article LECO investigates counterfeit drugs and how fentanyl is sometimes used to create them.

From LECO Corporation 1 Apr 2022

Protein analysis made easy with FP828

Protein analysis made easy with FP828

In this article, LECO speaks with Express Micro Science (EMS), the only food nutritional laboratory in Scotland, who made the choice to switch to LECO for their protein analysis tools.

From LECO Corporation 1 Apr 2022

Using GC-TOFMS to characterize citrus aromas

Using GC-TOFMS to characterize citrus aromas

This article discusses the difference between two citrus aromas - lemons and limes - at an analyte level. Analyzing and understanding these differences can be tricky, but holds the key to using these aromas in a wide range of applications, like essential oils.

From LECO Corporation 1 Apr 2022

GCxGC-MS holds the key to tastier veggie burgers

GCxGC-MS holds the key to tastier veggie burgers

With the rise of sustainable practices, plant-based food is gradually becoming more prevalent in everyday life. This article describes how GCxGC-MS could offer opportunities for better, tastier veggie burgers.

From LECO Corporation 1 Apr 2022

Tips on filing an Investigational New Drug application

Tips on filing an Investigational New Drug application

This article discusses the protocol for filing Investigational New Drug Applications (INDs).

From DSI, a PLG Company 30 Mar 2022

Using the CatWalk XT to perform gait analysis on rodents

Using the CatWalk XT to perform gait analysis on rodents

This article focuses on applications of the CatWalk XT and its importance for the gait analysis of rodents.

From Noldus Information Technology 15 Mar 2022

Previous
1
...
28
29
30
31
32
33
34
...
46
Next

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.